Sugi Predict

Sugi Predict / Compounds / SCHEMBL64860

SCHEMBL64860

SCHEMBL64860

CC(=O)CCCCCCCCCCC(C)=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAOX Q6QHF9 5/20 0.72
▸ ALDH1A1 P00352 4/20 0.64
▸ ACHE P22303 1/20 0.55
▸ LMNA P02545 2/20 0.50
▸ SLC15A2 Q16348 1/20 0.50
▸ TSHR P16473 4/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ PMP22 Q01453 1/20 0.47
▸ CES2 O00748 3/20 0.45
▸ CES1 P23141 3/20 0.45
▸ TDP1 Q9NUW8 3/20 0.44
▸ PPARG P37231 4/20 0.43
▸ PPARD Q03181 4/20 0.43
▸ PPARA Q07869 4/20 0.43
▸ GPR84 Q9NQS5 3/20 0.43
▸ HDAC11 Q96DB2 3/20 0.43
▸ SLC22A6 Q4U2R8 1/20 0.43
▸ SLC22A8 Q8TCC7 1/20 0.43
▸ TLR2 O60603 1/20 0.43
▸ MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12686704 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL316713 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL14749721 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL11435600 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL16723870 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL3626142 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL11375880 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL2775487 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL8421741 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL21818217 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4393922-A1 IRAK4 DEGRADATION AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Leadingtac Pharmaceutical Co. Ltd. (CN) 2024-07-03 — — EP disclosed
US-20230295180-A1 PROTEIN DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-09-21 — — US disclosed
EP-4194457-A1 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Leadingtac Pharmaceutical Co., Ltd. (CN) 2023-06-14 — — EP disclosed
EP-4194553-A1 MODIFIED SIRNA WITH REDUCED OFF-TARGET ACTIVITY Tuojie Biotech (Shanghai) Co., Ltd. (CN) 2023-06-14 — — EP disclosed
CN-107001214-B Process for producing cyclic diketone compound 花王株式会社 2021-03-23 — — CN disclosed
WO-2020162693-A1 SELF-HEALING INFRARED TRANSMITTING POLYIMIDE OPTICAL POLYMER MATERIAL HAVING HIGH REFRACTIVE INDEX, AND COMPOSITE THEREOF 연세대학교 산학협력단 2020-08-13 — — WO disclosed
WO-2020067079-A1 METHOD FOR PRODUCING 3-METHYLCYCLOALKENONE COMPOUND 高砂香料工業株式会社 2020-04-02 — — WO disclosed
US-20190169342-A1 POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. 2019-06-06 — — US disclosed
US-10087129-B2 Method for producing cyclic diketone compound KAO CORPORATION (JP) 2018-10-02 — — US disclosed
EP-3130343-B1 POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS RELYPSA INC (US) 2018-05-09 — — EP disclosed
US-20080020322-A1 PHOTOSENSITIVE ORGANIC SEMICONDUCTOR COMPOSITIONS BANK OF AMERICA, N.A., AS AGENT 2008-01-24 — — US disclosed
US-20080020322-A1 PHOTOSENSITIVE ORGANIC SEMICONDUCTOR COMPOSITIONS BANK OF AMERICA, N.A., AS AGENT 2008-01-24 — — US disclosed
US-20070278459-A1 PHOTOSENSITIVE ORGANIC SEMICONDUCTOR COMPOSITIONS LENHARD JEROME R 2007-12-06 — — US disclosed
US-20070278459-A1 PHOTOSENSITIVE ORGANIC SEMICONDUCTOR COMPOSITIONS LENHARD JEROME R 2007-12-06 — — US disclosed
US-20070254233-A1 ELECTROPHOTOGRAPHIC IMAGE FORMING METHOD AND IMAGE FORMING APPARATUS KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2007-11-01 — — US disclosed
US-7268363-B2 Photosensitive organic semiconductor compositions EASTMAN KODAK COMPANY (US) 2007-09-11 — — US disclosed
US-7268363-B2 Photosensitive organic semiconductor compositions EASTMAN KODAK COMPANY (US) 2007-09-11 — — US disclosed
US-7238457-B2 Electrophotographic photoreceptor KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2007-07-03 — — US disclosed
US-20070019984-A1 Organic photoconductor, process cartridge and image forming apparatus both employing the same KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2007-01-25 — — US disclosed
US-20070003853-A1 Image forming method, photoreceptor KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2007-01-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10087129-B2 Method for producing cyclic diketone compound AOC2, AOX1, HSD17B12 PAOX 975/4885ALDH1A1 320/4885ACHE 3768/4885
US-20230295180-A1 PROTEIN DEGRADERS AND USES THEREOF MDM2, CUL1, PSMG3 PAOX 774/4885ALDH1A1 3843/4885ACHE 3327/4885
US-20190169342-A1 POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS NR1H4, SLC10A2, ITCH PAOX 2443/4885ALDH1A1 4043/4885ACHE 3544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.